Strategy tested by COVID-19 pandemic
The COVID-19 pandemic put the effectiveness of SFS’ business strategy to the test. The strategic alignment has proven to be robust and correct:
- For SFS, close customer relationships are essential. In line with the "local for local" strategy, SFS is steadily building up its global development and production platform. Thanks to short and robust supply chains a superior supply reliability was realized.
- The balanced focus on different end markets, regions and sales channels cushioned the consequences of the decline in demand.
- With its increased focus on the medical device industry SFS is attractively positioned for the future.
- Thanks to its good profitability and solid balance sheet, SFS has the means and the ability to pursue its longterm strategy and to make the associated investments even in such a crisis.